Feldman & Pinto

Banner

  • Home
  • About Us
  • Practice Areas
  • Case Investigations
  • News
    • Firm News
    • Law News
  • Contact Us

Meme-Busting: Tort Reform = Cost Control

 On June 2, 2011 the Washington Post published an article written by Aaron Carroll, a doctor, highlighting the upcoming presidential election and health care reform.

"With the presidential election coming up, and health care still a hot issue, I’ve been preparing a series to highlight some of the “memes” that continue to permeate our debate, even when evidence suggests they aren’t true.

For better or for worse, whenever many are asked about how they would help control the cost of the health-care system, tort reform always seems to be one of the first things offered as a solution.

The argument goes that doctors, afraid of being sued, order lots of extra tests and procedures to protect themselves. This is known as defensive medicine. Tort reform assumes that if we put a cap on the damages plaintiffs can win, then filing cases will be less attractive, fewer claims will be made, insurance companies will save money, malpractice premiums will come down, doctors will feel safer and will practice less defensive medicine, and health-care spending will go way down.

Ergo, tort reform = cost control.

Let’s start with some basics. How much does the malpractice system really cost in the U.S.? The most recent, comprehensive estimate, which was published in Health Affairs in December, estimated that medical liability system costs were about $55.6 billion in 2008 dollars, or about 2.4 percent of all U.S. health-care spending. Some of that was indemnity payments, and some of it was the cost of components like lawyers, judges, etc.; most of this, however, or about $47 billion, was defensive medicine. So yes, that is real money, and it theoretically could be reduced.

The question is, will tort reform do that?"

To read the rest of this article please follow the link below

http://www.washingtonpost.com/blogs/ezra-klein/post/meme-busting-tort-reform--cost-control/2011/06/02/AGpb0DHH_blog.html

 

< Prev   Next >

Latest Law News

  • FDA Reviewing Stronger Warning Labels Regarding Blood Clots on Yaz Labels  
  • Hot Coffee Trailer 
  • Meme-Busting: Tort Reform = Cost Control 
  • FDA Warns Not to Feed Simply Thick to Premature Infants  
  • Birth Control Pills Containing Drospirenone: Possible Increased Risk of Blood Clots  
  • Paxil Cases Assigned to Savage, Over GlaxoSmithKline's Protests 
  • Judge Rules GSK's 'Nerve Center' in Phila. for Paxil Suits 
  • Oral Contraceptives and the Risk of Gall Bladder Disease: A Comparative Safety Study 
  • Asthma Relieving Advair Linked to Severe Asthma Attacks 
  • Wicked Understudy Sues Bayer Claiming Yasmin Caused Stroke 
  • Zicam Not Alone in Reports of Side Effects 
  • Yaz & The New York Times  
  • Paxil Related Birth Defects 
  • Early Cancer Diagnosis 
  • Diabetic Footcare 
  • Fines Unlikely to End Off-Label Drug Marketing 
  • Pfizer Expected to Pay Record Settlement to U.S. 
  • High Stakes for Merck in Litigation on Fosamax 
  • Bausch & Lomb Beats Back Lens-Cleaner Lawsuits 
  • 13 Years Later, Medical Malpractice Case Settled 


  • Home
  • About Us
  • Practice Areas
  • Case Investigations
  • News
  • Contact Us

All website content ©2013 Feldman & Pinto, All Rights Reserved | Contact Feldman & Pinto

FELDMAN & PINTO, ATTORNEYS AT LAW. 1604 Locust St, 2R  ·  Philadelphia, PA 19103  ·  Phone: 215-546-2604  ·  Fax: 215-546-9904

Disclaimer: Submissions of information through our online feature does not guarantee or create an attorney-client relationship between Feldman & Pinto and the person or entity submitting information. Feldman & Pinto will treat all submissions as confidential; however, we cannot guarantee the security of all online transmissions.